Global Blood Collection Tubes Market

Global Blood Collection Tubes Market Insights
The Global Blood Collection Tubes Market size was valued at USD 1.19 Billion in 2021, and it is expected to reach a value of USD 2.16 Billion by 2028, at a CAGR of 8.90% over the forecast period (2022 – 2028).
Blood collection tubes are sterile conditions plastic or glass tubes used to collect blood, urine, and serum samples from patients to diagnose blood-related diseases. Blood collection tubes are classified into several types, including sodium heparin blood collection tubes, serum separating tubes, vacutainer blood collection tubes, plasma separation tubes, and EDTA tubes. Vacutainer blood collection tubes come in a variety of sizes, including 16mm*100mm, 13mm*57mm, and 13mm*100mm. Vacutainer blood collection tubes are blood collector system tubes with push-button technology for safety mechanisms that help to protect the patient from needle stick injury. Blood samples are collected and safely stored in vacutainer blood collection tubes of this type.
Know more about : https://skyquestt.com/report/blood-collection-tubes-market

Global Blood Collection Tubes Market Segmental Analysis
The Global Blood Collection Tubes Market is segmented based on Test Tube Type, End-User, and Region. Based on Test Tube Type it is categorized into Heparin Tubes, Plasma Separation Tube, Serum Separating Tubes, EDTA Tubes, and Others, Based on End-User it is categorized into Diagnostic Centers, Healthcare Centers, Research and Development Centers. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Top Players Company Profiles
• Dickinson and Company (US)
• Haematonics (US)
• Terumo BCT (US)
• Fresenius Kabi AG (Germany)
• Grifols S.A. (Spain)
• Nipro Medical Corporation (Japan)
• Greiner Holding (Austria)
• Quest Diagnostics (US)
• SARSTEDT AG & Co. (Germany)
• Macopharma (France)

Recent Developments
• In April 2022, Blood Centers of America (BCA), America’s Blood Centers (ABC), and Fresenius Kabi announced their partnership for a nationwide effort in the United States to deliver critical blood collection and transfusion supplies to people affected in Ukraine.
• In March 2022, the U.S. Food and Drug Administration (FDA) cleared the new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company.
• In September 2021, Greiner Bio-One introduced the MiniCollect PIXIE Heel Incision Safety Lancet to expand its portfolio with a new safety lancet specifically designed for heel incision, and the company now offers three different lancet types to meet individual needs.
• In July 2021, Terumo Blood and Cell Technologies and CSL Plasma have announced a partnership to develop a new plasma collection platform.